LETYBO - Trademark Details
Status: 700 - Registered
Serial Number
79266012
Registration Number
6181983
Word Mark
LETYBO
Status
700 - Registered
Status Date
2020-10-27
Filing Date
2019-06-13
Registration Number
6181983
Registration Date
2020-10-27
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-08-11
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
MCMORROW, JANICE LEE
Statements
Goods and Services
Pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical products for skin care for animals; pharmaceutical preparations used in cosmetic surgery; pharmaceutical preparations containing botulinum toxin; botulinum toxin for medical use for use in the treatment of neuropathy pain; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; pharmaceutical preparations for use in treating urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; bacterial toxins, namely, bacterial poisons; pharmaceutical preparations for digestive system; pharmacological preparations for skin care; pharmaceutical preparations for treating peripheral neurological diseases and disorders; pharmaceutical preparations for treating central neurological diseases and disorders; ophthalmic preparations for use in the treatment of blepharospasm and strabismus; medicated ointments for treating dermatological conditions; chemical preparations for phamaceutical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; chemical preparations for phamaceutical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; chemical preparations for phamaceutical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; chemical preparations for phamaceutical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical agents for epidermis; drugs for medical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; biological preparations for medical or veterinary purposes for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; cultures of microorganisms for medical or veterinary use; chemical reagents for medical or veterinary purposes; bacteriological preparations for medical and veterinary use; adjuvants for medical purposes; hyaluronic acid preparations for medical purposes; medicines for human purpose, namely, medicines for skin care; pharmaceutical preparations for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of orthopaedic disorders, namely, hip dislocation, spinal column deformation, curvature of the spine, namely, scoliosis, lordosis, cyphosis; pharmaceutical preparations for smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, tremors and pain; pharmaceutical preparations for the treatment of wrinkles; injectable dermal filler; medicines for dental purposes; preparation for the relief of pain; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations mainly based on hyaluronic acid for treatments, namely, injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; therapeutic drugs and agents for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-09-04
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
James R Menker
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1484345
International Registration Date
2019-06-13
International Publication Date
2019-08-22
International Renewal Date
2029-06-13
Auto Protection Date
2021-02-22
International Status
001 - Request for extension of protection established
International Status Date
2019-08-22
Priority Claimed In
True
Priority Claimed Date
2018-12-21
First Refusal In
True
Trademark Events
Event Date | Event Description |
2019-08-22 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2019-08-26 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
2019-09-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-09-04 | ASSIGNED TO EXAMINER |
2019-09-05 | NON-FINAL ACTION WRITTEN |
2019-09-06 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2019-09-10 | APPLICATION FILING RECEIPT MAILED |
2019-09-16 | REFUSAL PROCESSED BY MPU |
2019-09-16 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2019-10-05 | REFUSAL PROCESSED BY IB |
2020-03-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-03-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-03-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-03-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-03-26 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-04-22 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-05-12 | PUBLISHED FOR OPPOSITION |
2020-05-12 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-07-06 | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST |
2020-07-22 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-07-22 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2020-07-22 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2020-08-07 | NOTIFICATION PROCESSED BY IB |
2020-08-11 | PUBLISHED FOR OPPOSITION |
2020-08-11 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-10-27 | REGISTERED-PRINCIPAL REGISTER |
2021-01-27 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2021-02-06 | FINAL DISPOSITION PROCESSED |
2021-02-06 | FINAL DISPOSITION NOTICE SENT TO IB |
2021-02-27 | NEW REPRESENTATIVE AT IB RECEIVED |
2021-03-07 | FINAL DECISION TRANSACTION PROCESSED BY IB |